Lv4
460 积分 2021-02-19 加入
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
26天前
已完结
Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
1个月前
已完结
Long-term efficacy, safety, and tolerability of xanomeline and trospium chloride in schizophrenia: A 52-week, open-label trial (EMERGENT-5)
1个月前
已完结
Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial
1个月前
已完结
慢性肾脏病防治的新纪元
7个月前
已完结
维奈克拉治疗不适合强诱导化疗的新诊断急性髓系白血病：真实世界使用以及医疗资源利用情况
7个月前
已关闭
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
7个月前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
8个月前
已关闭
Comparative Efficacy and Safety of Nine Anti-Platelet Therapies for Patients with Ischemic Stroke or Transient Ischemic Attack: a Mixed Treatment Comparisons
9个月前
已完结
皖公网安备34019202002308
